Thrivent Financial for Lutherans Grows Position in Mettler-Toledo International, Inc. $MTD

Thrivent Financial for Lutherans raised its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 9.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 80,786 shares of the medical instruments supplier’s stock after acquiring an additional 7,200 shares during the period. Thrivent Financial for Lutherans owned approximately 0.40% of Mettler-Toledo International worth $112,631,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of MTD. Geneos Wealth Management Inc. raised its holdings in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares in the last quarter. Baird Financial Group Inc. raised its holdings in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after acquiring an additional 40 shares in the last quarter. Jump Financial LLC raised its holdings in shares of Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after acquiring an additional 125 shares in the last quarter. Cerity Partners LLC raised its holdings in shares of Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after acquiring an additional 392 shares in the last quarter. Finally, AXA S.A. raised its holdings in shares of Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after acquiring an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

MTD has been the topic of several recent research reports. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday. Citigroup reduced their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. JPMorgan Chase & Co. reduced their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Finally, Morgan Stanley reduced their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $1,420.33.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,042.42 on Friday. The firm has a market cap of $21.07 billion, a P/E ratio of 24.45, a P/E/G ratio of 2.14 and a beta of 1.31. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The business’s 50 day moving average price is $1,248.06 and its 200-day moving average price is $1,356.03.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. The firm had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities analysts predict that Mettler-Toledo International, Inc. will post 46.59 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.